ES2045182T3 - Substancias fisiologicamente activas, un proceso para la preparacion de las mismas y composiciones farmaceuticas que las contienen. - Google Patents

Substancias fisiologicamente activas, un proceso para la preparacion de las mismas y composiciones farmaceuticas que las contienen.

Info

Publication number
ES2045182T3
ES2045182T3 ES88810502T ES88810502T ES2045182T3 ES 2045182 T3 ES2045182 T3 ES 2045182T3 ES 88810502 T ES88810502 T ES 88810502T ES 88810502 T ES88810502 T ES 88810502T ES 2045182 T3 ES2045182 T3 ES 2045182T3
Authority
ES
Spain
Prior art keywords
active substances
physiologically active
contain
preparation
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88810502T
Other languages
English (en)
Inventor
Yoji Institute Of Bi Shibayama
Yoshio Institute Of B Toyomaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Zoki Pharmaceutical Co Ltd
Original Assignee
Nippon Zoki Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co Ltd filed Critical Nippon Zoki Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2045182T3 publication Critical patent/ES2045182T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE EXTRAEN SUSTANCIAS FISIOLOGICAMENTE ACTIVAS DE TEJIDOS DE INSECTOS INOCULADOS CON UN VIRUS DE SIFILIS. TIENEN ACCION INHIBIDORA CONTRA LA FORMACION DE CALICREINA Y SON UTILES COMO MEDICAMENTOS, TALES COMO AGENTES ANTIINFLAMATORIOS, ANALGESICOS Y ANTIALERGICOS.
ES88810502T 1987-07-23 1988-07-21 Substancias fisiologicamente activas, un proceso para la preparacion de las mismas y composiciones farmaceuticas que las contienen. Expired - Lifetime ES2045182T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62184981A JP2651674B2 (ja) 1987-07-23 1987-07-23 新規生理活性物質及びその製造方法

Publications (1)

Publication Number Publication Date
ES2045182T3 true ES2045182T3 (es) 1994-01-16

Family

ID=16162710

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88810502T Expired - Lifetime ES2045182T3 (es) 1987-07-23 1988-07-21 Substancias fisiologicamente activas, un proceso para la preparacion de las mismas y composiciones farmaceuticas que las contienen.

Country Status (6)

Country Link
US (1) US5057324A (es)
EP (1) EP0300973B1 (es)
JP (1) JP2651674B2 (es)
AT (1) ATE84721T1 (es)
DE (1) DE3877647T2 (es)
ES (1) ES2045182T3 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4985254A (en) * 1987-11-06 1991-01-15 Nippon Zoki Pharmaceutical Co., Ltd. Method of treating ischemic diseases
JP2539674B2 (ja) * 1987-11-06 1996-10-02 日本臓器製薬株式会社 新規生理活性物質
EP0341209B1 (en) * 1988-04-30 1993-09-15 Nippon Zoki Pharmaceutical Co. Ltd. Physiologically active substances, a process for preparation and pharmaceutical compositions thereof
JP2588109B2 (ja) * 1993-03-19 1997-03-05 日本臓器製薬株式会社 鎮痛剤
JP3213832B2 (ja) * 1993-08-06 2001-10-02 日本臓器製薬株式会社 被検物質の活性測定法
JP3213831B2 (ja) * 1993-08-06 2001-10-02 日本臓器製薬株式会社 被検物質の活性測定方法
JP2594222B2 (ja) * 1993-09-28 1997-03-26 日本臓器製薬株式会社 新規生理活性物質−ｋｆ
JP4033936B2 (ja) * 1997-01-08 2008-01-16 日本臓器製薬株式会社 一酸化窒素産生抑制剤
AU721804B2 (en) * 1997-01-08 2000-07-13 Nippon Zoki Pharmaceutical Co., Ltd. Nitrogen monoxide production suppressor
JPH1180005A (ja) * 1997-09-12 1999-03-23 Nippon Zoki Pharmaceut Co Ltd 骨粗鬆症治療剤
KR19990044835A (ko) 1997-11-28 1999-06-25 고니시 진우에몬 생약추출물
CN100425692C (zh) * 1998-06-02 2008-10-15 株式会社富吉摩托普拉泽兹 含有高质量生理活性的家兔发痘组织的制造方法
CA2305825A1 (en) 1999-04-15 2000-10-15 Nippon Zoki Pharmaceutical Co., Ltd. Novel bioactivating substance
US6726932B2 (en) 2000-02-18 2004-04-27 Nippon Zoki Pharmaceutical Co., Ltd. Fatty acid-containing composition
US6913900B2 (en) * 2001-08-29 2005-07-05 Nippon Zoki Pharmaceutical Co., Ltd. Plasma prekallikrein activation and kallikrein production assay
CN1207005C (zh) * 2002-10-31 2005-06-22 威世药业（如皋）有限公司 含生物活性物质的兔皮和其用途
KR101097138B1 (ko) * 2002-10-31 2011-12-22 니폰 조키 세야쿠 가부시키가이샤 섬유근통증 치료제
KR101307999B1 (ko) 2004-12-01 2013-09-12 니폰 조키 세야쿠 가부시키가이샤 건조물 및 그 제조방법
US20060134646A1 (en) * 2004-12-17 2006-06-22 Ansari Aftab A Method for treatment of HIV infection
TWI483729B (zh) 2010-03-11 2015-05-11 Nippon Zoki Pharmaceutical Co 慢性前列腺炎、間質性膀胱炎及／或排尿障礙之改善或治療劑
AU2011316756B2 (en) 2010-10-14 2015-01-22 Nippon Zoki Pharmaceutical Co., Ltd A method for promoting the synthesis of collagen and proteoglycan in chondrocytes
TWI737229B (zh) 2013-04-30 2021-08-21 日商日本臟器製藥股份有限公司 製劑的製造方法、製劑製造的管理方法及製劑的檢查方法
CN105663166B (zh) * 2016-03-02 2020-04-17 中国人民解放军疾病预防控制所 特异性抗天花病毒感染模型毒株的生物活性制剂及应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53101515A (en) * 1977-02-17 1978-09-05 Nippon Zoki Pharmaceutical Co Medicine having anodyne * sedative and antiallergic activity and production thereof
JPS54130502A (en) * 1978-03-31 1979-10-09 Nippon Zoki Pharmaceutical Co Physiological active substance*its manufacture and medical composition
JPS5528943A (en) * 1978-08-22 1980-02-29 Nippon Zoki Pharmaceut Co Ltd Medicinal composition
JPS5587724A (en) * 1978-12-27 1980-07-02 Nippon Zoki Pharmaceut Co Ltd Selective immune enhancer
JPS5775991A (en) * 1980-10-27 1982-05-12 Nippon Zoki Pharmaceut Co Ltd Novel physiologically active substance jcv-80
JPS5777697A (en) * 1980-11-04 1982-05-15 Nippon Zoki Pharmaceut Co Ltd Physiologically active substance nsq
JPS5835117A (ja) * 1981-08-25 1983-03-01 Nippon Zoki Pharmaceut Co Ltd 新規生理活性物質ｎｓｈ
JPS59118711A (ja) * 1982-12-25 1984-07-09 Nippon Zoki Pharmaceut Co Ltd 新規生理活性物質

Also Published As

Publication number Publication date
DE3877647D1 (de) 1993-03-04
ATE84721T1 (de) 1993-02-15
JPS6429389A (en) 1989-01-31
EP0300973A1 (en) 1989-01-25
US5057324A (en) 1991-10-15
DE3877647T2 (de) 1993-05-13
EP0300973B1 (en) 1993-01-20
JP2651674B2 (ja) 1997-09-10

Similar Documents

Publication Publication Date Title
DE3877647D1 (de) Physiologisch wirksame produkte, verfahren zur herstellung und zusammensetzung.
UY26372A1 (es) "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen "
SE8602723L (sv) Tiazoler, deras framstellning och farmaceutiska kompositioner innehallande dem
AR004700A1 (es) 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento
DE59102210D1 (de) Galanthemin enthaltende pharmazeutische Formulierung zur Behandlung des Alkoholismus.
ES2233931T3 (es) Fenilacetato y derivados, solos o en combinacion con otros compuestos, contra estados neoplasicos y otros trastornos.
AR020001A1 (es) COMPUESTOS ACTIVADORES DE hPPARGAMMA Y hPPARALFA, COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN, METODO PARA EL TRATAMIENTO Y/O PREVENCION DE UNAENFERMEDAD MEDIADA POR LOS MISMOS, Y SU USO PARA LA ELABORACION DE UN MEDICAMENTO
ES550807A0 (es) Un procedimiento para la produccion de un preparado farmaceutico de liberacion lenta y controlada.
EA200100154A1 (ru) Бензоциклогептены, способ их получения, содержащие их фармацевтические препараты и их применение для получения лекарственных средств
ES2061727T3 (es) Sustancias fisiologicamente activas, un procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
ES2084579T3 (es) Uso de buspirona en la preparacion de una composicion farmaceutica para el tratamiento del abuso del alcohol.
PT98371A (pt) Processo para a preparacao de derivados 6-alcoxi de arabinofuranosil-guanina e de composicoes farmaceuticas que os contem
ATE239474T1 (de) Verwendung von levobupivacain
ES2173858T3 (es) Analogos de huperzina a.
ES2193233T3 (es) Uso de amiodipina, una sal de la misma o felodipina en combinacion con un inhibidor ace en la fabricacion de un medicamento para el tratamiento de insuficiencia cardiaca conjuntiva no isquemica.
ATE193442T1 (de) 3,4-diarylchromane zur behandlung von dermatitis
ES2059816T3 (es) Sustancias activas fisiologicamente, un procedimiento para la preparacion y composiciones farmaceuticas de las mismas.
ES2020171T3 (es) Eteres de 1-bencil-3-hidroximetilindazol con 2-hidroxiacidos alifaticos.
ES2054718T3 (es) El uso de gepirona para la preparacion de una composicion farmaceutica para el tratamiento de la depresion atipica.
ES2043943T3 (es) Procedimiento para la preparacion de compuestos con actividad analgesica central.
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
FR2657872B2 (fr) Derive d'amidino-4 chromanne, procede d'obtention et compositions pharmaceutiques le contenant.
IT8720438A0 (it) Esteri di 1,4:3,6-dianidrosorbitolo-2-mononitrato e 5-mononitrato, loro procedimento di preparazione e loro composizioni farmaceutiche.
ES2043736T3 (es) Acidos 3,5-dihidroxi-heptanoicos sustituidos con (1h-pirrol-3-ilo) en posicion 7, sus correspondientes delta-lactonas y sales, procedimientos para su preparacion, su utilizacion como medicamentos, preparados farmaceuticos y productos intermedios.
PT989994E (pt) Derivados de estreptograminas, a sua preparacao e as composicoes que os contem

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 300973

Country of ref document: ES